Eversept Partners’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,631
Closed -$1.7M 79
2021
Q1
$1.7M Buy
+27,631
New +$1.7M 0.13% 59